Allogeneic hematopoietic stem cell transplantation in adult acute myeloid leukemia with t(16;21)(p11;q22)/FUS::ERG
- PMID: 39658629
- DOI: 10.1038/s41375-024-02495-1
Allogeneic hematopoietic stem cell transplantation in adult acute myeloid leukemia with t(16;21)(p11;q22)/FUS::ERG
Conflict of interest statement
Ethics approval and consent to participate: This study was approved by the Japanese Data Center for Hematopoietic Cell Transplantation and the Institutional Review Board of Kobe City Medical Center General Hospital and conducted in accordance with the Declaration of Helsinki (approval number: zn240506). Written informed consent was obtained from each patient at each institution before Transplant Registry Unified Management Program 2 registration. Competing interests: Shohei Mizuno received research funding from Hayashikane Sangyo and lecture fees from Janssen Pharmaceutical. The other authors declare no conflicts of interest associated with this manuscript.
References
-
- Kong XT, Ida K, Ichikawa H, Shimizu K, Ohki M, Maseki N, et al. Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16; 21)(p11; q22) and identification of a novel transcript. Blood. 1997;90:1192–9. - PubMed
LinkOut - more resources
Full Text Sources
